The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance

Hong Ruan1, Henry J Pownall

  • 1University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Department of Physiology and Biophysics, 683 Hoes Lane West, Piscataway, NJ 08854, USA. ruanho@umdnj.edu

Current Opinion in Investigational Drugs (London, England : 2000)
|April 2, 2009
PubMed

Insights

Insulin resistance, a key factor in type 2 diabetes (T2D), is linked to obesity. The inhibitor of kappaB kinase (IKK)/NFkappaB pathway in adipose tissue plays a role in this insulin resistance, offering a potential therapeutic target.

Area of Science:

  • Metabolic diseases
  • Endocrinology
  • Molecular biology

Background:

  • Insulin resistance is a fundamental defect in type 2 diabetes (T2D), particularly when associated with obesity.
  • Adipose tissue, beyond energy storage, secretes factors influencing energy metabolism and insulin sensitivity.
  • Obese adipose tissue exhibits altered secretory profiles, impacting adipocyte function and systemic insulin sensitivity.

Purpose of the Study:

  • To review recent data on pathways contributing to insulin resistance in obesity.
  • To evaluate the role of the inhibitor of kappaB kinase (IKK)/NFkappaB pathway in insulin sensitivity.
  • To assess the therapeutic potential of targeting the IKK/NFkappaB pathway in T2D.

Main Methods:

  • Review of in vitro and in vivo studies.
  • Analysis of signaling pathways and transcriptional regulators.
  • Examination of cross-talk between adipose and non-adipose tissues.

Main Results:

  • The IKK/NFkappaB pathway is implicated in regulating insulin sensitivity.
  • This pathway is involved in both fatty acid and inflammatory cytokine signaling cascades.
  • Obesity-associated insulin resistance involves complex signaling in adipose tissue.

Conclusions:

  • The IKK/NFkappaB pathway is a significant factor in obesity-linked insulin resistance.
  • Targeting the IKK/NFkappaB pathway presents a potential therapeutic strategy for T2D.
  • Understanding adipose-derived factors and their signaling is crucial for T2D research.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...